<DOC>
	<DOCNO>NCT00159003</DOCNO>
	<brief_summary>There naturally occur variation genetic makeup u . Some variation may contribute change susceptibility toward different disease change prognosis . We study genetic variation patient leukemia . The gene study influence detoxification drug toxin .</brief_summary>
	<brief_title>Analysis Genetic Factors Related Predisposition Prognosis Hematological Malignancies Israel</brief_title>
	<detailed_description>We prepare DNA patient leukemia ( AML , CML CLL ) study influence polymorphisms drug metabolism disposition gene predisposition prognosis type leukemia . The gene study include : MDR1 , CYP3A4 , NQO1 , NAT1/2 , GST , hOCT . We plan study gene may contributory . Study include compare frequency polymorphism gene frequency general population study DNA biding protein bind site polymorphism .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<criteria>diagnosis acute myeloid leukemia chronic lymphocytic leukemia 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>drug metabolism disposition enzyme</keyword>
</DOC>